AI Enabled Medical Device Software (AI-DSF) Market Size, Share, Scope Report 2026 to 2035
What is AI Enabled Medical Device Software (AI-DSF) Market Size?
AI Enabled Medical Device Software (AI-DSF) Market Size is valued at USD 9.09 Bn in 2025 and is predicted to reach USD 47.36 Bn by the year 2035 at a 18.2% CAGR during the forecast period for 2026 to 2035.
AI Enabled Medical Device Software (AI-DSF) Market Size, Share & Trends Analysis by Device Type (Diagnostic Imaging AI, Remote Patient Monitoring, AI-Assisted Surgical Robotics, Clinical Decision Support), by Application (Radiology, Cardiology, Oncology, Neurology), by End User (Hospitals, Diagnostic Labs, Ambulatory Surgical Centers), and Segment Forecasts, 2026 to 2035
Artificial intelligence is reshaping how medical devices work. Instead of being limited to basic monitoring, devices now use smart software to help doctors and nurses diagnose problems, track patients, and even guide decisions about care. These systems rely on technologies like machine learning and natural language processing to make sense of large volumes of healthcare data. The result is faster, more accurate diagnoses and more time for clinicians to focus on complex tasks. Patients benefit too, with better outcomes and more personalized treatment.
Healthcare providers are increasingly adopting these AI‑enabled solutions because they improve efficiency and reduce workload. By automating routine processes and analyzing data in real time, the software makes medical devices more intelligent and responsive to patient needs. This shift is already changing the way care is delivered, and the momentum is growing.
The market for AI‑based medical device software has expanded rapidly. Rising demand for digital healthcare tools, the need for data‑driven decision‑making, and the growing burden of chronic diseases are all driving adoption. Aging populations and higher healthcare spending add further pressure to find smarter solutions. At the same time, advances in cloud computing, data analytics, and connected devices have opened new opportunities for innovation. Regulators across different regions are also supporting the development and commercialization of AI‑powered medical technologies, which has accelerated growth.
Competitive Landscape
Which are the Leading Players in AI-Enabled Medical Device Software (AI-DSF) Market?
• Siemens Healthineers AG
• GE HealthCare Technologies Inc.
• Philips Healthcare
• Medtronic plc
• Johnson & Johnson MedTech
• Abbott Laboratories
• Boston Scientific Corporation
• Intuitive Surgical Inc.
• Tempus AI Inc.
• Aidoc Medical Ltd.
• Viz.ai Inc.
• Qure.ai Technologies Pvt. Ltd.
• Zebra Medical Vision
• Fujifilm Holdings Corporation
• Canon Medical Systems Corporation
• Nvidia Corporation
• Oracle Health
• IBM Corporation
• Microsoft Corporation
• Google Health
Market Dynamics
Driver
Growing Adoption of AI-Powered Diagnostic and Clinical Decision Support Systems
Artificial intelligence is steadily becoming a core part of modern medical devices. Hospitals and doctors are turning to AI‑powered tools to support diagnosis and treatment decisions, and the results are proving valuable. These systems can spot potential health issues earlier, interpret medical images with greater accuracy, and provide actionable insights that guide clinical choices. For medical professionals, this means faster, more reliable information at the point of care.
The growing investments by healthcare organizations in advanced technologies such as connected devices are further accelerating this trend. By integrating AI‑based software, institutions can streamline operations, reduce errors in diagnosis, and improve efficiency across departments. The ultimate benefit is better patient outcomes, achieved through smarter, more responsive systems. As adoption increases, the role of AI in medical devices is expected to expand even further. With its ability to enhance precision, minimize workload, and support timely interventions, AI is positioning itself as a cornerstone of the future healthcare ecosystem.
Restrain/Challenge
Regulatory Complexity and Data Privacy Concerns
Navigating changing regulations is one of the main challenges facing the global market for AI-based medical device software. For these products to reach the market, companies must put their software through extensive testing to show it works safely and effectively.
AI-powered software relies on large amounts of personal data to train its algorithms. As a result, protecting patient information, preventing cyberattacks, and following rules like HIPAA and GDPR are top concerns for the industry.
Hospitals Segment is Expected to Drive the AI-Enabled Medical Device Software (AI-DSF) Market
Market share wise, the largest proportion was contributed by the hospitals segment in 2025. Hospitals produce huge amounts of data from their patients and require AI-based solutions in order to help enhance the accuracy of diagnosis and treatment, as well as streamline operations and patient monitoring. In addition, hospitals have been investing heavily in digital transformation and healthcare technology in recent times. This is expected to positively impact the growth of this segment going forward.
Computer Vision Segment is Growing at the Highest Rate in the AI-Enabled Medical Device Software (AI-DSF) Market
For the year 2025, it was found that computer vision emerged as a leading category within the software for AI-enabled medical devices market. The capabilities of computer vision help medical devices and software platforms in analyzing and identifying medical imaging for any abnormalities. Moreover, the growing acceptance of AI-based radiology, pathology, and ophthalmology is also helping to boost this segment.
Why North America Led the AI-Enabled Medical Device Software (AI-DSF) Market?
North America led the AI-enabled medical device software market due to its advanced healthcare infrastructure, strong medical device industry, high adoption of digital health technologies, and early regulatory activity around AI-enabled medical devices. The United States has a large base of hospitals, diagnostic imaging networks, software developers, medical device manufacturers, and AI-focused health technology companies.
The region also benefits from active FDA authorization pathways for AI-enabled medical devices, strong venture capital funding, and growing hospital investment in workflow automation, diagnostic imaging AI, remote patient monitoring, and clinical decision support. Canada contributes through digital health adoption, research partnerships, and AI innovation hubs.
Asia Pacific is expected to grow rapidly during the forecast period, supported by increasing healthcare digitization, growing diagnostic imaging volumes, expanding hospital infrastructure, rising chronic disease burden, and increasing investment in AI-driven healthcare technologies.
Key Development
• In August 2025, The U.S. FDA issued guidance on predetermined change control plans for AI-enabled medical devices. The guidance supports iterative software improvement while maintaining safety and effectiveness standards for AI-enabled device software.
• In March 2025, GE HealthCare and NVIDIA announced a collaboration to advance autonomous diagnostic imaging, with a focus on AI-driven autonomous X-ray and ultrasound solutions. The collaboration highlights the growing role of AI in next-generation imaging devices.
AI Enabled Medical Device Software (AI-DSF) Market Report Scope:
| Report Attribute | Specifications |
| Market size value in 2025 | USD 9.09 Bn |
| Revenue forecast in 2035 | USD 47.36 Bn |
| Growth Rate CAGR | CAGR of 18.2% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Device Type, Application, End User, and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Siemens Healthineers, GE HealthCare, Philips Healthcare, Medtronic, Johnson & Johnson MedTech, Abbott, Boston Scientific, Intuitive Surgical, Tempus AI, Aidoc, Viz.ai, Qure.ai, Fujifilm, Canon Medical Systems, Nvidia, Oracle Health, IBM, Microsoft, and Google Health. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Market Segmentation:
AI-Enabled Medical Device Software (AI-DSF) Market by Device Type -
• Diagnostic Imaging AI
• Remote Patient Monitoring
• AI-Assisted Surgical Robotics
• Clinical Decision Support
AI-Enabled Medical Device Software (AI-DSF) Market by Application -
• Radiology
• Cardiology
• Oncology
• Neurology
AI-Enabled Medical Device Software (AI-DSF) Market by End-user-
• Hospitals
• Diagnostic Labs
• Ambulatory Surgical Centers
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
AI Enabled Medical Device Software (AI-DSF) Market Size is valued at USD 9.09 Bn in 2025 and is predicted to reach USD 47.36 Bn by the year 2035
AI Enabled Medical Device Software (AI-DSF) Market predicted to grow at a 18.2% CAGR during the forecast period for 2026 to 2035.
AI Enabled Medical Device Software (AI-DSF) Market is segmented into Device Type, Application, End User, and By Region
Siemens Healthineers, GE HealthCare, Philips Healthcare, Medtronic, Johnson & Johnson MedTech, Abbott, Boston Scientific, Intuitive Surgical, Tempus AI, Aidoc, Viz.ai, Qure.ai, Fujifilm, Canon Medical Systems, Nvidia, Oracle Health, IBM, Microsoft, and Google Health.
North America region is leading the AI Enabled Medical Device Software (AI-DSF) Market.